Progress in the Development of Respiratory Syncytial Virus and Parainfluenza Virus Vaccines
Open Access
- 15 December 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (12) , 1668-1677
- https://doi.org/10.1086/379775
Abstract
Respiratory syncytial virus (RSV) and human parainfluenza viruses (hPIVs) are leading causes of viral lower respiratory tract illness in children andKeywords
This publication has 104 references indexed in Scilit:
- Severe Lower Respiratory Tract Infections Associated with Human Parainfluenza Viruses 1-3 in Children Infected and Noninfected with HIV Type 1European Journal of Clinical Microbiology & Infectious Diseases, 2002
- A Chimeric Human-Bovine Parainfluenza Virus Type 3 Expressing Measles Virus Hemagglutinin Is Attenuated for Replication but Is Still Immunogenic in Rhesus MonkeysJournal of Virology, 2001
- Evaluation of a Live, Cold‐Passaged, Temperature‐Sensitive, Respiratory Syncytial Virus Vaccine Candidate in InfancyThe Journal of Infectious Diseases, 2000
- Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infantsThe Pediatric Infectious Disease Journal, 1996
- Safety and immunogenicity of a subunit respiratory syncytial virus vacine in children 24 to 48 months oldThe Pediatric Infectious Disease Journal, 1994
- An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccinesVirus Research, 1994
- Parainfluenza Virus Type 3: Seasonality and Risk of Infection and Reinfection in Young ChildrenThe Journal of Infectious Diseases, 1984
- Cold adaptation of parainfluenza virus type 3: Induction of three phenotypic markersJournal of Medical Virology, 1982
- Respiratory-Syncytial-Virus Infections, Reinfections and ImmunityNew England Journal of Medicine, 1979
- Evaluation of a live, attenuated respiratory syncytial virus vaccine in infantsThe Journal of Pediatrics, 1976